Cargando…

Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model

BACKGROUND: Asthma is a multifactorial disease for which a variety of mouse models have been developed. A major drawback of these models is represented by the transient nature of the airway pathology peaking 24–72 h after challenge and resolving in 1–2 weeks. We characterized the temporal evolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Stellari, Fabio, Sala, Angelo, Ruscitti, Francesca, Carnini, Chiara, Mirandola, Prisco, Vitale, Marco, Civelli, Maurizio, Villetti, Gino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619338/
https://www.ncbi.nlm.nih.gov/pubmed/26496719
http://dx.doi.org/10.1186/s12967-015-0696-5
_version_ 1782397079312662528
author Stellari, Fabio
Sala, Angelo
Ruscitti, Francesca
Carnini, Chiara
Mirandola, Prisco
Vitale, Marco
Civelli, Maurizio
Villetti, Gino
author_facet Stellari, Fabio
Sala, Angelo
Ruscitti, Francesca
Carnini, Chiara
Mirandola, Prisco
Vitale, Marco
Civelli, Maurizio
Villetti, Gino
author_sort Stellari, Fabio
collection PubMed
description BACKGROUND: Asthma is a multifactorial disease for which a variety of mouse models have been developed. A major drawback of these models is represented by the transient nature of the airway pathology peaking 24–72 h after challenge and resolving in 1–2 weeks. We characterized the temporal evolution of pulmonary inflammation and tissue remodeling in a recently described mouse model of chronic asthma (8 week treatment with 3 allergens: Dust mite, Ragweed, and Aspergillus; DRA). METHODS: We studied the DRA model taking advantage of fluorescence molecular tomography (FMT) imaging using near-infrared probes to non-invasively evaluate lung inflammation and airway remodeling. At 4, 6, 8 or 11 weeks, cathepsin- and metalloproteinase-dependent fluorescence was evaluated in vivo. A subgroup of animals, after 4 weeks of DRA, was treated with Budesonide (100 µg/kg intranasally) daily for 4 weeks. RESULTS: Cathepsin-dependent fluorescence in DRA-sensitized mice resulted significantly increased at 6 and 8 weeks, and was markedly inhibited by budesonide. This fluorescent signal well correlated with ex vivo analysis such as bronchoalveolar lavage eosinophils and pulmonary inflammatory cell infiltration. Metalloproteinase-dependent fluorescence was significantly increased at 8 and 11 weeks, nicely correlated with collagen deposition, as evaluated histologically by Masson’s Trichrome staining, and airway epithelium hypertrophy, and was only partly inhibited by budesonide. CONCLUSIONS: FMT proved suitable for longitudinal studies to evaluate asthma progression, showing that cathepsin activity could be used to monitor inflammatory cell infiltration while metalloproteinase activity parallels airway remodeling, allowing the determination of steroid treatment efficacy in a chronic asthma model in mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0696-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4619338
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46193382015-10-26 Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model Stellari, Fabio Sala, Angelo Ruscitti, Francesca Carnini, Chiara Mirandola, Prisco Vitale, Marco Civelli, Maurizio Villetti, Gino J Transl Med Research BACKGROUND: Asthma is a multifactorial disease for which a variety of mouse models have been developed. A major drawback of these models is represented by the transient nature of the airway pathology peaking 24–72 h after challenge and resolving in 1–2 weeks. We characterized the temporal evolution of pulmonary inflammation and tissue remodeling in a recently described mouse model of chronic asthma (8 week treatment with 3 allergens: Dust mite, Ragweed, and Aspergillus; DRA). METHODS: We studied the DRA model taking advantage of fluorescence molecular tomography (FMT) imaging using near-infrared probes to non-invasively evaluate lung inflammation and airway remodeling. At 4, 6, 8 or 11 weeks, cathepsin- and metalloproteinase-dependent fluorescence was evaluated in vivo. A subgroup of animals, after 4 weeks of DRA, was treated with Budesonide (100 µg/kg intranasally) daily for 4 weeks. RESULTS: Cathepsin-dependent fluorescence in DRA-sensitized mice resulted significantly increased at 6 and 8 weeks, and was markedly inhibited by budesonide. This fluorescent signal well correlated with ex vivo analysis such as bronchoalveolar lavage eosinophils and pulmonary inflammatory cell infiltration. Metalloproteinase-dependent fluorescence was significantly increased at 8 and 11 weeks, nicely correlated with collagen deposition, as evaluated histologically by Masson’s Trichrome staining, and airway epithelium hypertrophy, and was only partly inhibited by budesonide. CONCLUSIONS: FMT proved suitable for longitudinal studies to evaluate asthma progression, showing that cathepsin activity could be used to monitor inflammatory cell infiltration while metalloproteinase activity parallels airway remodeling, allowing the determination of steroid treatment efficacy in a chronic asthma model in mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0696-5) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-24 /pmc/articles/PMC4619338/ /pubmed/26496719 http://dx.doi.org/10.1186/s12967-015-0696-5 Text en © Stellari et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Stellari, Fabio
Sala, Angelo
Ruscitti, Francesca
Carnini, Chiara
Mirandola, Prisco
Vitale, Marco
Civelli, Maurizio
Villetti, Gino
Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
title Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
title_full Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
title_fullStr Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
title_full_unstemmed Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
title_short Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
title_sort monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619338/
https://www.ncbi.nlm.nih.gov/pubmed/26496719
http://dx.doi.org/10.1186/s12967-015-0696-5
work_keys_str_mv AT stellarifabio monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel
AT salaangelo monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel
AT ruscittifrancesca monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel
AT carninichiara monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel
AT mirandolaprisco monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel
AT vitalemarco monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel
AT civellimaurizio monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel
AT villettigino monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel